Chronogesic DURECT

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


DURECT Corp is developing Chronogesic, a subcutaneous implant (DUROS) formulation of the synthetic opioid analgesic sufentanil, for the potential treatment of chronic pain resulting from a variety of causes, including head and neck, lower back, arthritis and cancer pain.

Original languageEnglish (US)
Pages (from-to)368-371
Number of pages4
Issue number4
StatePublished - Apr 1 2003

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Chronogesic DURECT'. Together they form a unique fingerprint.

Cite this